These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 12894546)

  • 1. Assessment of in vitro drug resistance of human breast cancer cells subcultured from biopsy specimens.
    Krasna L; Netikova I; Chaloupkova A; Taislova E; Zimovjanova M; Vesely P; Danes J; Petruzelka L; Matouskova E
    Anticancer Res; 2003; 23(3B):2593-9. PubMed ID: 12894546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A simple non-destructive test of cellular activity (NTCA) for in vitro assessment of cancer cell chemosensitivity/resistance.
    Netikova I; Bursikova E; Vesely P; Prchalova M; Kleibl Z; Matouskova E
    Anticancer Res; 2007; 27(4B):2331-7. PubMed ID: 17695522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Establishment of transplantable human colon cancer cell lines, chemosensitivity of colon carcinomas and the serially transplantable strains with MTT assay].
    Kase S; Kubota T; Furukawa T; Yamaguchi H; Takeuchi T; Takahara T; Suto A; Kodaira S; Ishibiki K
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2247-53. PubMed ID: 1929445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chemosensitivity test for gastric cancer by in vitro MTT assay].
    Ohyama S; Yonemura Y; Kinoshita K; Ninomiya I; Tugawa K; Kimura H; Miyazaki I; Tanaka M; Endo Y; Sasaki T
    Gan To Kagaku Ryoho; 1991 Aug; 18(10):1593-7. PubMed ID: 1908213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemosensitivity test with endoscopic biopsy specimens].
    Wada K; Sato Y; Kawashima M; Yamauchi M; Kaneshiro K; Kondo T
    Gan To Kagaku Ryoho; 1995 Apr; 22(5):671-7. PubMed ID: 7717720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.
    Chen X; Yeung TK; Wang Z
    Biochem Biophys Res Commun; 2000 Nov; 277(3):757-63. PubMed ID: 11062025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chemosensitivity test for thyroid cancer by in vitro MTT assay].
    Sasaki F; Ishimura H; Takada N; Uchino J
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1777-81. PubMed ID: 7574809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of predictability of in vitro SDI assay in comparison with in vivo nude mouse assay].
    Fujita M; Tanigawa K; Fujita F; Sakamoto Y; Shimozuma K; Kusuyama T; Inaba H; Taguchi T
    Gan To Kagaku Ryoho; 1989 Oct; 16(10):3435-41. PubMed ID: 2802637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of in vitro chemosensitivity of antitumor drugs using the MTT assay in fresh human breast cancer.
    Xu JM; Song ST; Tang ZM; Liu XQ; Jiang ZF; Zhou L; Li YB; Huang Y
    Breast Cancer Res Treat; 1998 Jun; 49(3):251-9. PubMed ID: 9776509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination treatment with fulvestrant and various cytotoxic agents (doxorubicin, paclitaxel, docetaxel, vinorelbine, and 5-fluorouracil) has a synergistic effect in estrogen receptor-positive breast cancer.
    Ikeda H; Taira N; Nogami T; Shien K; Okada M; Shien T; Doihara H; Miyoshi S
    Cancer Sci; 2011 Nov; 102(11):2038-42. PubMed ID: 21801281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidermal growth factor receptor (HER1) tyrosine kinase inhibitor ZD1839 (Iressa) inhibits HER2/neu (erbB2)-overexpressing breast cancer cells in vitro and in vivo.
    Moulder SL; Yakes FM; Muthuswamy SK; Bianco R; Simpson JF; Arteaga CL
    Cancer Res; 2001 Dec; 61(24):8887-95. PubMed ID: 11751413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro chemosensitivity test for seven undifferentiated thyroid carcinoma cell lines using MTT assay].
    Osawa Y; Yoshida A; Asaga T; Kawahara S; Yanoma S
    Gan To Kagaku Ryoho; 1996 Mar; 23(4):471-6. PubMed ID: 8678500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The MTS assay as an indicator of chemosensitivity/resistance in malignant gynaecological tumours.
    O'Toole SA; Sheppard BL; McGuinness EP; Gleeson NC; Yoneda M; Bonnar J
    Cancer Detect Prev; 2003; 27(1):47-54. PubMed ID: 12600417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin-induced Aurora-A suppression not only causes mitotic defect and cell cycle arrest but also alters chemosensitivity to anticancer drugs.
    Ke CS; Liu HS; Yen CH; Huang GC; Cheng HC; Huang CY; Su CL
    J Nutr Biochem; 2014 May; 25(5):526-39. PubMed ID: 24613085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary correlations of clinical outcome with in vitro chemosensitivity of second passage human breast cancer cells.
    Smith HS; Zoli W; Volpi A; Hiller A; Lippman M; Swain S; Mayall B; Dollbaum C; Hackett AJ; Amadori D
    Cancer Res; 1990 May; 50(10):2943-8. PubMed ID: 2334895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of Fra-1 in estrogen receptor-negative breast cancers and suppression of their propagation in vivo by ascochlorin, an antibiotic that inhibits cellular activator protein-1 activity.
    Nakajima H; Mizuta N; Sakaguchi K; Fujiwara I; Mizuta M; Furukawa C; Chang YC; Magae J
    J Antibiot (Tokyo); 2007 Nov; 60(11):682-9. PubMed ID: 18057697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Chemosensitivity test of breast cancer].
    Oura S; Tanino H; Naito Y
    Nihon Rinsho; 2000 Apr; 58 Suppl():581-6. PubMed ID: 11026054
    [No Abstract]   [Full Text] [Related]  

  • 18. [Predictive value of in vitro MTT assay chemosensitivity test of cytotoxic drug activity in cervical cancer].
    Xiao Y; Li JD; Shi HL; Liu JH; Feng YL; Li MD
    Ai Zheng; 2007 Apr; 26(4):386-9. PubMed ID: 17430657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemosensitivity testing of clinical gastrointestinal cancers using histoculture and the MTT end-point.
    Furukawa T; Kubota T; Watanabe M; Kase S; Takahara T; Yamaguchi H; Takeuchi T; Teramoto T; Ishibiki K; Kitajima M
    Anticancer Res; 1992; 12(5):1377-82. PubMed ID: 1444194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathologic features of retinoblastoma and its relation with in vitro drug resistance measured by means of the MTT assay.
    Schouten-van Meeteren AY; van der Valk P; van der Linden HC; Moll AC; Imhof SM; Huismans DR; Loonen AH; Veerman AJ
    Cancer; 2001 Dec; 92(11):2933-40. PubMed ID: 11753969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.